1688 Inorganic Chemistry, Vol. 40, No. 7, 2001
Wagner et al.
1
FAB+-MS, m/z: 517 [M + Na]+, 494 [M]+, 458 [M - HCl]+, 421
[M - HONdCMe2]+, 385 [M - HONdCMe2 - HCl]+, 348 [M -
2HONdCMe2 - HCl]+. IR spectrum (selected bands), cm-1: 3222 m
ν(N-H), 1666 and 1646 s ν(CdN), 1173 m ν(C-O). 1H NMR in
CDCl3, δ: 2.02 and 2.03 (two s, 3H each, (dCMe2), 2.64 (s, 3H, Nd
CMe), 7.92 (br, 1H, NH). 13C{1H} NMR in CDCl3, δ: 17.1 and 21.8
(dCMe2), 19.4 (NdCMe), 164.1 (NdCMe2), 170.5 (HNdC). 195Pt
NMR in CDCl3, δ: -2040 (770 Hz).
1157 m ν(C-O). H NMR in CDCl3, δ: 2.30 (s, 3H, NdCMe), 3.98
and 4.05 (two d, 13.2 Hz, 2H each, (CH2Ph), 7.29 (m, 4H) and 7.36
(m, 6H) (CH2Ph), 8.14 (br, 1H, NH). 13C{1H} NMR in CDCl3, δ: 18.4
(NdCMe), 61.5 (CH2Ph), 128.3, 128.8, 129.6 and 133.9 (CH2Ph), 171.1
(HNdC). 195Pt NMR in CDCl3, δ: -2033 (580 Hz).
[Ph3PCH2Ph][PtCl3{NHdC(Et)ONdCMe2}]. Anal. Calcd for
C31H34N2Cl3OPPt: C, 47.55; H, 4.38; N, 3.58. Found: C, 46.38; H,
4.12; N, 3.41. FAB--MS, m/z: 429 [Manion]+. IR spectrum in KBr,
selected bands, cm-1: 3308 m-w ν(N-H), 3056 m-w and 2927 m
[PtCl2{NHdC(Me)ONdCMeEt}2]. Anal. Calcd for C12H24N4Cl2O2-
Pt: C, 27.59; H, 4.63; N, 10.73. Found: C, 28.01; H, 4.69; N, 10.70.
FAB+-MS, m/z: 522 [M]+, 486 [M - HCl]+, 450 [M - HCl - Cl]+.
IR spectrum (selected bands), cm-1: 3210 m ν(N-H), 1659 and 1643
1
ν(C-H), 1643 s ν(CdN), 1110 s-m ν(P-C). H NMR in CDCl3, δ:
7.7 (m, 15H, Ph), 7.1 (m, 5H, CH2Ph), 5.17 (d, JPH 14.0 Hz, 2H, CH2-
Ph), 3.11 (quart, JHH 7.6 Hz, 2H, Et), 1.24 (t, JHH 7.6 Hz, 3H, Et), 1.94
(s, 6H, dCMe2). 13C{1H} NMR in CDCl3, δ: 30.7 (1JPC 51.1 Hz, CH2-
Ph), 117.5 (1JPC 84.6 Hz, Cipso from Ph), 127.1 (2JPC 8.4 Hz, Cipso from
CH2Ph),128.3 (JPC 3.7 Hz, CHp from Ph), 128.7 (JPC 2.9 Hz, CHm from
Ph), 130.2 (JPC 12.7 Hz, CH from Ph), 131.5 (JPC 5.3 Hz, CHo from
CH2Ph), 134.3 (JPC 10.1 Hz, CH from Ph), 134.9 (JPC 2.7 Hz, CHp
from Ph), 163.4 (CdN from ONdCMe2), 172.6 (CdN from HNd
C(Et)), 26.7 (CH2 from Et), 10.1 (CH3 from Et), 16.9 and 21.8 (dCMe2).
31P{1H} in CDCl3, δ: 23.6. 195Pt NMR in CDCl3, δ: -1811 (660 Hz).
[Ph3PCH2Ph][PtCl3{NHdC(Et)ONdC(C4H8)}]. Anal. Calcd for
C33H36N2Cl3OPPt: C, 48.99; H, 4.48; N, 3.46. Found: C, 48,43; H,
4.51; N, 3.36. FAB--MS, m/z: 454 [Manion - H]+. IR spectrum in KBr,
selected bands, cm-1: 3311 m-w ν(N-H), 3057 m-w and 2927 m
1
s ν(CdN), 1177 m ν(C-O). H NMR in CDCl3, δ: 1.13 (t, 7.5 Hz,
major signal), 1.09 (t, 7.5 Hz, minor signal), 2.34 (quart., 7.8 Hz, major
signal) and 2.42 (quart., 7.8 Hz, minor signal) (Et), 1.99 (s, major signal)
and 2.00 (s, minor signal) (Me), 2.57 (s, major signal) and 2.56 (minor
signal) (HNdC(Me)), 7.91 (br, NH). 13C{1H} NMR in CDCl3, δ: 19.3
(major signal) and 19.5 (minor signal) (HNdCMe), 10.3 (major signal),
9.9 (minor signal), 29.2 (major signal) and 24.0 (minor signal) (Et),
15.6 (major signal) and 19.4 (minor signal) (Me), 168.7 (major signal)
and 169.5 (minor signal) (NdC), 170.9 (HNdC). 195Pt NMR in CDCl3,
δ: -2088 (800 Hz). EtMeCdNOH exists as an equilibrium mixture of
ca. 75% E and 25% Z isomer; therefore two sets of signals for the
ligand in an approximate ratio of 4:1 were expected and observed.
[PtCl2{NHdC(Me)ONdC(CH2)4}2]. Anal. Calcd for C14H24N4-
Cl2O2Pt: C, 30.78; H, 4.43; N, 10.25. Found: C, 30.96; H, 4.82; N,
10.05. FAB+-MS, m/z: 546 [M]+, 510 [M - Cl]+. IR spectrum
(selected bands), cm-1: 3220 m ν(N-H), 1651 s ν(CdN), 1170 m
ν(C-O). 1H NMR in CDCl3, δ: 1.82 (m, 4H) and 2.47 (m, 4H)
(dC(CH2)4), 2.54 (s, 3H, NdCMe), 7.83 (br, 1H, NH). 13C{1H} NMR
in CDCl3, δ: 19.4 (NdCMe), 24.4, 24.9, 29.6 and 31.4 ((CH2)4), 176.6
(NdC(CH2)4), 171.0 (HNdC). 195Pt NMR in CDCl3, δ: -2088 (840
Hz).
1
ν(C-H), 1646 s ν(CdN), 1110 s-m ν(P-C). H NMR in CDCl3, δ:
7.7 (m, 15H, Ph), 7.1 (m, 5H, CH2Ph), 5.21 (d, JPH 14.0 Hz, 2H, CH2-
Ph), 3.11 (quart, JHH 7.6 Hz, 2H, Et), 1.25 (t, JHH 7.6 Hz, 3H, Et), 2.42
(m, 4H, R-CH2 from dC(C4H8)), 1.78 (m, 4H, â-CH2 from dC(C4H8)).
13C{1H} NMR in CDCl3, δ: 30.7 (1JPC 45.0 Hz, CH2Ph), 117.5 (1JPC
84.6 Hz, Cipso from Ph), 127.1 (2JPC 8.4 Hz, Cipso from CH2Ph), 128.3
(JPC 3.7 Hz, CHp from Ph), 128.7 (JPC 2.9 Hz, CHm from Ph), 130.2
(JPC 12.7 Hz, CH from Ph), 131.5 (JPC 5.3 Hz, CHo from CH2Ph), 134.3
(JPC 10.1 Hz, CH from Ph), 134.9 (JPC 2.7 Hz, CHp from Ph), 174.9
(CdN from ONdC(C4H8)2), 172.8 (CdN from HNdC(Et)), 26.6 (CH2
from Et), 10.2 (CH3 from Et), 31.2 and 29.2 (R-CH2 from dC(C4H8)),
24.9 and 24.4 (â-CH2 from dC(C4H8)). 31P{1H} in CDCl3, δ: 23.6.
195Pt NMR in CDCl3, δ: -1808 (625 Hz).
[PtCl2{NHdC(Me)ONdC(CH2)5}2]. Anal. Calcd for C16H28N4-
Cl2O2Pt: C, 33.46; H, 4.91; N, 9.75. Found: C, 33.42; H, 5.05; N,
9.79. FAB+-MS, m/z: 597 [M + Na]+, 575 [M + H]+, 539 [M -
Cl]+, 539 [M - Cl - HCl]+. IR spectrum (selected bands), cm-1: 3209
1
m ν(N-H), 1663 and 1643 s ν(CdN), 1180 m ν(C-O). H NMR in
[Ph3PCH2Ph][PtCl3{NHdC(Et)ONdC(C5H10)}]. Anal. Calcd for
C34H38N2Cl3OPPt: C, 49.61; H, 4.65; N, 3.40. Found: C, 49.06; H,
4.64; N, 3.30. FAB+-MS, m/z: 468 [Manion - H]+. IR spectrum in KBr,
selected bands, cm-1: 3307 m-w ν(N-H), 3057 m-w, 2932 and 2859
m-w ν(C-H), 1639 s ν(CdN), 1109 s-m ν(P-C). 1H NMR in CDCl3,
δ: 7.7 (m, 15H, Ph), 7.1 (m, 5H, CH2Ph), 5.15 (d, JPH 14.3 Hz, 2H,
CH2Ph), 3.10 (quart, JHH 8.3 Hz, 2H, Et), 1.24 (t, JHH 8.3 Hz, 3H, Et),
2.46 (t, JHH 5 Hz, 2H, CH2 from dC(C5H10)), 2.23 (t, JHH 5.6 Hz, 2H,
CH2 from dC(C5H10)) 1.64 (m, 6H, CH2 from dC(C5H10)). 13C{1H}
NMR in CDCl3, δ: 30.7 (1JPC 53 Hz, CH2Ph), 117.5 (1JPC 86.7 Hz,
Cipso from Ph), 127.0 (2JPC 8.4 Hz, Cipso from CH2Ph), 128.3 (JPC 3.7
Hz, CHp from Ph), 128.7 (JPC 2.8 Hz, CHm from Ph), 130.2 (JPC 12.8
Hz, CH from Ph), 131.5 (JPC 5.4 Hz, CHo from CH2Ph), 134.3 (JPC 9.2
Hz, CH from Ph), 134.9 (JPC 2.8 Hz, CHp from Ph), 168.0 (CdN from
ONdCMe2), 172.8 (CdN from HNdCEt), 10.1 (CH3 from Et), 26.8
(CH2 from Et), 31.9 and 26.7 (R-CH2 from dC(C5H10)), 26.6, 25.6
and 25.2 (â- and γ-CH2 from dC(C5H10)). 31P{1H} NMR in CDCl3,
δ: 23.6. 195Pt NMR in CDCl3, δ: -1807 (700 Hz).
CDCl3, δ: 1.67 (m, 4H), 1.77 (m, 2H), 2.34 (t, 6.6 Hz, 2H) and 2.54
(t, 6.6 Hz, 2H) (dC(CH2)5), 2.59 (s, 3H, NdCMe), 7.92 (br, 1H, NH).
13C{1H} NMR in CDCl3, δ: 19.6 (NdCMe), 25.1, 25.7, 26.7, 27.1
and 31.9 ((CH2)5), 169.8 (NdC(CH2)5 and HNdC). 195Pt NMR in
CDCl3, δ: -2091 (680 Hz).
[PtCl2{NHdC(Me)ONdC(Me)C(Me)dNOH}2]. Anal. Calcd for
C12H22N6Cl2O4Pt: C, 24.84; H, 3.82; N, 12.22. Found: C, 25.12; H,
4.10; N, 12.13. FAB+-MS, m/z: 603 [M + Na]+, 580 [M]+, 545 [M -
Cl]+. IR spectrum (selected bands), cm-1: 3241 m ν(N-H), 1670 s
1
ν(CdN), 1189 m ν(C-O). H NMR in acetone-d6, δ: 2.09 and 2.18
(two s, 3H each, (dC(Me)C(Me)), 2.67 (s, 3H, NdCMe), 8.50 (br,
1H, NH). 13C{1H} NMR in acetone-d6, δ: 9.7 and 11.6 (dC(Me)C-
(Me)), 19.6 (NdCMe), 153.0 and 163.7 (two ONdC), 170.7 (HNd
C). 195Pt NMR in acetone-d6, δ: -2055 (400 Hz).
[PtCl2{NHdC(Me)ONMe2}2]. Anal. Calcd for C8H20N4Cl2O2Pt: C,
20.43; H, 4.29; N, 11.91. Found: C, 20.58; H, 4.18; N, 11.77. FAB+-
MS, m/z: 469 [M]+, 433 [M - Cl]+, 398 [M - 2Cl]+. IR spectrum in
1
KBr, selected bands, cm -1: 3247 m ν(N-H), 1665 s ν(CdN). H
NMR in CDCl3, δ: 2.48 (s, 3H, dCMe), 2.73 (s, 6H, NMe2) 8.05 (s,
br, 1H, NH). 13C{1H} NMR in CDCl3, δ: 18.8 (Me), 47.5 (NMe2),
170.7 (CdN). 195Pt NMR in CDCl3, δ: -2047 (800 Hz).
[PtCl2{NHdC(Me)ON(Me)CHR}2] (R ) Ph, C6H4Me). Isolated
1
yield is 99% (R ) Ph) and 87% (R ) C6H4Me). H, 13C{1H}, and
195Pt NMR are identical to those already described.12
[PtCl2{NHdC(Me)ONEt2}2]. Anal. Calcd for C12H28N4Cl2O2Pt: C,
27.38; H, 5.35; N, 10.64. Found: C, 27.57; H, 5.28; N, 10.55. FAB+-
MS, m/z: 526 [M]+, 454 [M - 2HCl]+. IR spectrum in KBr, selected
bands, cm -1: 3256 m-w ν(N-H), 1665 s ν(CdN). 1H NMR in
CDCl3, δ: 2.51 (s, 3H, dCMe), 1.09 (t, 7.2 Hz, 6H), 2.90 (quart., 6.6
Hz, 2H) and 2.91 (quart., 7.2 Hz, 2H) (NEt2) 8.15 (s, br, 1H, NH).
13C{1H} NMR in CDCl3, δ: 18.4 (Me), 11.6 and 52.7 (NEt2), 172.3
(CdN). 195Pt NMR in CDCl3, δ: -2028 (700 Hz).
[PtCl2{NHdC(Me)ON(CH2Ph)2}2]. Anal. Calcd for C32H36N4Cl2O2-
Pt: C, 49.62; H, 4.68; N, 7.23. Found: C, 49.80; H, 4.57; N, 7.14.
FAB+-MS, m/z: 797 [M + Na]+, 774 [M]+, 738 [M - HCl]+. IR
spectrum (selected bands), cm-1: 3271 m ν(N-H), 1655 s ν(CdN),
Reduction of Other Platinum(IV) Complexes. The reduction
proceeds similarly to the reduction of imine complexes, and NMR yields
are almost quantitative. All platinum(II) products from the reaction are
known, and their formation was confirmed by NMR spectroscopy (data
obtained are given below) and when possible by comparison of other
characteristics with those of known compounds.
trans-[PtCl2(HONdCMe2)2]:83 from the reduction of trans-[PtCl4-
(HONdCMe2)2]. 1H NMR in CDCl3, δ: 2.15 and 2.61 (two s, 3H each,
J
PtH not observed, NdCMe2), 9.80 (1H, OH). 13C{1H} NMR in CDCl3,
δ: 19.2 and 26.8 (NdCMe2), 164.0 (NdC). 195Pt NMR in CDCl3, δ:
-1998 (480 Hz).